Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Ameren Illinois (AILIO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Ameren Illinois (AILIO) over the last 17 years, with Q3 2025 value amounting to $988.0 million.

  • Ameren Illinois' Capital Expenditures fell 1310.47% to $988.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 billion, marking a year-over-year increase of 870.53%. This contributed to the annual value of $4.3 billion for FY2024, which is 2007.23% up from last year.
  • As of Q3 2025, Ameren Illinois' Capital Expenditures stood at $988.0 million, which was down 1310.47% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Ameren Illinois' Capital Expenditures registered a high of $1.3 billion during Q4 2024, and its lowest value of $98.0 million during Q3 2021.
  • Over the past 5 years, Ameren Illinois' median Capital Expenditures value was $899.0 million (recorded in 2022), while the average stood at $866.3 million.
  • Per our database at Business Quant, Ameren Illinois' Capital Expenditures plummeted by 8506.1% in 2021 and then skyrocketed by 81734.69% in 2022.
  • Over the past 5 years, Ameren Illinois' Capital Expenditures (Quarter) stood at $866.0 million in 2021, then grew by 5.54% to $914.0 million in 2022, then grew by 12.25% to $1.0 billion in 2023, then grew by 25.73% to $1.3 billion in 2024, then fell by 23.41% to $988.0 million in 2025.
  • Its Capital Expenditures was $988.0 million in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.